NeuroNova AB Prepares For Next Phase By Appointing New CEO
10/19/2005 5:12:21 PM
NeuroNova AB, a private Swedish biopharmaceutical company pioneering therapeutic neurogenesis for disorders of the central nervous system , announced today the appointment of Ulf Ljungberg, PhD, as its new President and Chief Executive Officer. Dr Ljungberg replaces Anders Haegerstrand, MD, PhD, who will assume the position of Vice President and Chief Scientific Officer within the Company. Dr Ljungberg’s appointment is effective immediately.